ESR1 and breast cancer: We analyzed the ratio of Myc-positive tissues in ERα-negative and ERα-positive malignant breast cancers, and Myc positivity was higher in ERα-positive tissues than in ERα-negative tissues (Figure 4B graph, negative 43.58% versus positive 93.10%).